KeyCorp CEO Beth Mooney to Retire in May
KeyCorp. Chief Executive and Chairman Beth Mooney is retiring from the regional lender in May and will be replaced by the head of Key's retail bank, Chris Gorman in both roles.
Huawei Launches First Smartphone Without Google's Key Apps
Huawei unveiled its first smartphone devoid of Google's most popular apps, a byproduct of the U.S.-China trade dispute that could complicate the Chinese tech giant's efforts to stoke demand for its products.
Zuckerberg Meets With Trump, Faces Tough Questions from Senators
With his company under a regulatory spotlight, Facebook's Mark Zuckerberg scored a meeting at the White House Thursday-but faced a chillier reception from lawmakers on Capitol Hill.
AT&T Sale of DirecTV Would Be No Blockbuster
Separating DirecTV would remove cash flows that AT&T needs to pay a dividend and service debt.
Amazon to Add 100,000 Electric Vehicles as Part of Climate Pledge
Amazon.com plans to buy 100,000 electric delivery vehicles as it seeks to reduce its carbon emissions in the face of criticism of its environmental impact.
PG&E Bondholders Ally With Wildfire Victims to Propose New Bankruptcy Exit Plan
Court papers filed by a group of PG&E bondholders, including Elliott Management and by the official committee representing fire victims, asked for the green light to put a chapter 11 plan on the table that would compete with the company's own restructuring framework.
Ping Identity Listing Marks IPO Milestone for Vista
Ping, which made its debut on the New York Stock Exchange Thursday, is the first Vista portfolio company to go public since the firm's launch in 2000
Colt Defense to Stop Producing AR-15 Rifles for Civilians
Gun maker Colt Defense LLC said it would stop producing semiautomatic rifles for civilians, citing a glut in the market.
Fentanyl Drug Finds New Home in First Opioid Crisis Bankruptcy Deal
Insys Therapeutics won bankruptcy-court approval to sell Subsys, the opioid that spawned criminal racketeering charges against its top executives and set off investigations and lawsuits that plunged the company into bankruptcy.
Purdue Led Its Opioid Rivals in Pills More Prone to Abuse
When taking into account the dosage strength of each pill, Purdue Pharma's OxyContin represented a market-leading 27% of total oxycodone sold during a seven-year period reviewed by The Wall Street Journal.
(END) Dow Jones Newswires
September 19, 2019 21:00 ET (01:00 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.